Two Sigma Advisers LP boosted its position in shares of UiPath Inc. (NYSE:PATH - Free Report) by 29.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,901,000 shares of the company's stock after buying an additional 1,100,800 shares during the period. Two Sigma Advisers LP owned 0.89% of UiPath worth $62,292,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Smartleaf Asset Management LLC increased its stake in UiPath by 88.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,454 shares of the company's stock worth $31,000 after buying an additional 1,152 shares in the last quarter. First Horizon Advisors Inc. increased its stake in UiPath by 47.8% during the 4th quarter. First Horizon Advisors Inc. now owns 2,487 shares of the company's stock worth $32,000 after buying an additional 804 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in UiPath by 141.4% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,974 shares of the company's stock worth $38,000 after buying an additional 1,742 shares in the last quarter. V Square Quantitative Management LLC increased its stake in UiPath by 33.4% during the 4th quarter. V Square Quantitative Management LLC now owns 3,030 shares of the company's stock worth $39,000 after buying an additional 759 shares in the last quarter. Finally, Harvest Fund Management Co. Ltd purchased a new stake in UiPath during the 4th quarter worth approximately $50,000. 62.50% of the stock is currently owned by hedge funds and other institutional investors.
UiPath Price Performance
PATH traded up $0.05 during trading hours on Friday, reaching $12.39. The company's stock had a trading volume of 9,253,854 shares, compared to its average volume of 10,928,750. UiPath Inc. has a fifty-two week low of $9.38 and a fifty-two week high of $19.09. The stock has a market cap of $6.83 billion, a PE ratio of -77.44 and a beta of 1.01. The business's 50-day moving average is $11.34 and its 200-day moving average is $12.71.
Insider Activity at UiPath
In other UiPath news, CFO Ashim Gupta sold 98,795 shares of the company's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $12.01, for a total transaction of $1,186,527.95. Following the transaction, the chief financial officer now directly owns 987,322 shares in the company, valued at $11,857,737.22. This represents a 9.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Hitesh Ramani sold 12,500 shares of the company's stock in a transaction on Thursday, April 3rd. The stock was sold at an average price of $10.19, for a total value of $127,375.00. Following the transaction, the chief accounting officer now owns 314,891 shares in the company, valued at $3,208,739.29. This trade represents a 3.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. 23.19% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on PATH shares. Barclays cut their price objective on UiPath from $15.00 to $12.00 and set an "equal weight" rating for the company in a research note on Thursday, March 13th. Mizuho dropped their price target on UiPath from $12.00 to $11.00 and set a "neutral" rating for the company in a research report on Tuesday, April 15th. Wells Fargo & Company dropped their price target on UiPath from $13.00 to $11.00 and set an "equal weight" rating for the company in a research report on Thursday, March 13th. Evercore ISI dropped their price target on UiPath from $16.00 to $12.00 and set an "in-line" rating for the company in a research report on Thursday, March 13th. Finally, BMO Capital Markets dropped their price target on UiPath from $16.00 to $11.50 and set a "market perform" rating for the company in a research report on Friday, March 14th. Two investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $12.72.
Get Our Latest Analysis on UiPath
About UiPath
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Articles

Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.